2008至2017年急性卒中患者有创机械通气与气管造口术的美国全国费用估算
该回顾性观察研究利用2008至2017年美国全国住院患者样本,估算急性缺血性卒中、脑出血和蛛网膜下腔出血患者接受有创机械通气(IMV)、气管造口术或无通气的住院费用。结果显示,气管造口术患者占卒中入院1.4%但占美国卒中住院费用的9.5%,且等待气管造口术每延迟一天费用增加2.9%。
要点
- 急性卒中住院中9.4%接受单纯IMV,1.4%接受气管造口术。
- 气管造口术患者中位住院费用为95 380美元,远高于无IMV的9 503美元。
- 7天内行气管造口术的费用低于7天后(中位71 470美元 vs 102 979美元)。
核心结论
- 接受气管造口术的急性卒中患者占卒中入院的1.4%,占美国卒中住院费用的9.5%。
- 未来研究应关注IMV和气管造口术对社会和患者的附加价值,尤其是气管造口术在7天后进行时费用增加且卒中预后差。
研究设计与样本
- 回顾性观察研究,使用2008至2017年美国全国住院患者样本,纳入急性缺血性卒中、脑出血和蛛网膜下腔出血住院患者。
- 按通气状态分为无IMV、单纯IMV和气管造口术三组,使用成本收费比调整至2017年美元计算住院费用。
主要发现
- 估算急性卒中住院5.2百万例(95% CI,5.1-5.3),其中9.4%接受单纯IMV,1.4%接受气管造口术。
- 无IMV患者中位住院4天(IQR,2-6),单纯IMV为6天(IQR,2-13),气管造口术为25天(IQR,18-36),P<0.001。
- 无IMV患者死亡率为3.2%,单纯IMV为51.2%,气管造口术为9.8%,P<0.001。
- 无IMV患者中位住院费用为9503美元(IQR,6544-14 963),单纯IMV为23 774美元(IQR,10 900-47 735),气管造口术为95 380美元(IQR,63 921-144 019)。
- 7天内气管造口术的中位费用为71 470美元(IQR,47 863-108 250),低于7天后的102 979美元(IQR,69 563-152 543),P<0.001。
关键数值与推荐
- 等待气管造口术每延迟一天与费用增加2.9%相关(95% CI,2.6%-3.1%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with stroke receiving invasive mechanical ventilation (IMV) and tracheostomy incur intense treatment and long hospitalizations. We aimed to evaluate US hospitalization costs for patients with stroke requiring IMV, tracheostomy, or no ventilation. METHODS: We performed a retrospective observational study of US hospitalizations for acute ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage receiving IMV, tracheostomy, or none using the National Inpatient Sample, 2008 to 2017. We calculated hospitalization costs using cost-to-charge ratios adjusted to 2017 US dollars for inpatients with stroke by ventilation status (no IMV, IMV alone, tracheostomy). RESULTS: Of an estimated 5.2 million (95% CI, 5.1-5.3) acute stroke hospitalizations, 2008 to 2017; 9.4% received IMV alone and 1.4% received tracheostomy. Length of stay for patients without IMV was shorter (median, 4 days; interquartile range [IQR], 2-6) compared with IMV alone (median, 6 days; [IQR, 2-13]), and tracheostomy (median, 25 days; [IQR, 18-36]; P<0.001). Mortality for patients without IMV was 3.2% compared with 51.2% for IMV alone and 9.8% for tracheostomy (P<0.001). Median hospitalization costs for patients without IMV was $9503 (IQR, $6544-$14 963), compared with $23 774 (IQR, $10 900-$47 735) for IMV alone and $95 380 (IQR, $63 921-$144 019) for tracheostomy. Tracheostomy placement in ≤7 days had lower costs compared with placement in >7 days (median, $71 470 [IQR, $47 863-$108 250] versus $102 979 [IQR, $69 563-$152 543]; P<0.001). Each day awaiting tracheostomy was associated with a 2.9% cost increase (95% CI, 2.6%-3.1%). US hospitalization costs for patients with acute stroke were $8.7 billion/y (95% CI, $8.5-$8.9 billion). For IMV alone, costs were $1.8 billion/y (95% CI, $1.7-$1.9 billion) and for tracheostomy $824 million/y (95% CI, $789.7-$858.3 million). CONCLUSIONS: Patients with acute stroke who undergo tracheostomy account for 1.4% of stroke admissions and 9.5% of US stroke hospitalization costs. Future research should focus on the added value to society and patients of IMV and tracheostomy, in particular after 7 days for the latter procedure given the increased costs incurred and poor outcomes in stroke.
引用
- Albert GP, McHugh DC, Hwang DY, et al. National Cost Estimates of Invasive Mechanical Ventilation and Tracheostomy in Acute Stroke, 2008-2017. Stroke. 2023. PMID: 37706340. doi:10.1161/STROKEAHA.123.043176
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。